Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
|ClinicalTrials.gov Identifier: NCT00281814|
Recruitment Status : Completed
First Posted : January 25, 2006
Last Update Posted : January 26, 2018
RATIONALE: Questionnaires that measure coping may improve the ability to plan supportive care for patients undergoing donor bone marrow transplant.
PURPOSE: This clinical trial is studying coping in patients who are undergoing a donor bone marrow transplant.
|Condition or disease||Intervention/treatment|
|Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Psychosocial Effects of Cancer and Its Treatment||Procedure: psychosocial assessment and care|
- Investigate the relative importance of having a consistent inpatient lay care-partner for patients undergoing allogeneic bone marrow transplantation, in terms of the effects on modes of adjustment to illness and survival.
OUTLINE: Patients undergo a 40-minute recorded oral interview in person to provide personal and social demographic data using a 20-item questionnaire (The Adjustment to Illness Questionnaire-Bone Marrow Transplantation) at baseline (pre-transplant) and at day 100 post-transplant.
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
|Study Type :||Observational|
|Actual Enrollment :||36 participants|
|Official Title:||Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support|
|Actual Study Start Date :||February 1, 2006|
|Actual Primary Completion Date :||December 31, 2008|
|Actual Study Completion Date :||January 4, 2017|
Procedure: psychosocial assessment and care
- Compare modes of illness adjustment, presence or absence of an inpatient lay care-partner, and survival rates [ Time Frame: Through 100 days post transplant ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00281814
|United States, Ohio|
|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|
|Cleveland, Ohio, United States, 44195|
|Study Chair:||Brian J. Bolwell, MD||Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|